UPM-Kymmene (UPM.HE) Stock Analysis & AI Equity Report

UPM-Kymmene (UPM.HE) overview

UPM-Kymmene (NASDAQ Helsinki: UPM.HE) stock analysis and AI equity research. UPM-Kymmene shares trade at 24.06 EUR; Valuatum rates UPM.HE HOLD with a 24.70 EUR 12-month price target (+2.7% vs the current share price). This Paper, Lumber & Forest Products equity research report covers UPM-Kymmene's valuation, segment-value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

52-week range 21.72 EUR – 27.94 EUR · 1-year change -1.7% · 3-year change -24.3%.

Executive summary

UPM-Kymmene Oyj (UPM.HE, NASDAQ Helsinki) is an integrated forest-products and renewable-materials group spanning pulp, forests, electricity, adhesives, papers, timber, plywood, biofuels, biochemicals and biomedical materials. The HOLD rating carries a 12-month target price of 24.70 EUR against a current price of 24.06 EUR, or +2.7% implied upside, in this Valuatum equity research report dated 1 September 2026. Market capitalisation is EUR 12.7 bn and enterprise value is EUR 15.8 bn. The investment case combines commodity exposure with renewable power, specialty conversion and emerging fossil-material substitutes across Finland, Uruguay, Germany and the United States.

The central tension is that value is concentrated in assets and earnings with different economic drivers. Pulp and plantations, Forest assets and wood sourcing, and Energy represent 56.0% of allocated enterprise value, while Communication Papers and Adhesive Materials carry more visible sales. The stock trades at 14.1x 2026E P/E and 8.6x 2026E EV/EBITDA, below UPM's normalised historical 11.01x EV/EBITDA but not on a comparable quality base. Uruguay pulp has a delivered-cost target of approximately USD 280 per tonne, forests exceed EUR 3.5 bn of assets, and Energy generated EUR 151m of comparable EBIT in 2025.

The target price is built primarily through a division-level SOTP using 2028E–2029E EBITDA, EBIT or revenue and peer-appropriate multiples, with a weighted target EV of EUR 17.80 bn less EUR 2.741 bn of net debt and EUR 418m of other adjustments. The base scenario produces 27.77 EUR per share and +15.4%, while the bear case produces 12.93 EUR per share and -46.3% and the bull case 37.82 EUR per share and +57.2%. The HOLD reflects moderate value support but several unresolved execution tests.

Investment thesis — three reasons

Thesis breaker: The thesis breaks if weak pulp pricing, high Finnish wood costs and a failed Leuna ramp jointly prevent EBITDA from sustainably exceeding EUR 1.7 bn.

Segment value analysis — enterprise-value allocation

The segment value analysis decomposes UPM-Kymmene's enterprise value into the distinct businesses and options the market is paying for, each shown with its share of total EV and segment economics.

Pulp and plantations — 25.0% · EUR 3,962m

Revenue EUR 2,400m (24.9%) · Comparable EBIT EUR 240m (26.1%, 10.0% margin) · EV EUR 3,962m

Pulp and plantations is the largest allocated pool because UPM controls 5.8 million tonnes of annual capacity, including 2.1 million tonnes at Paso de los Toros. Modelled revenue of EUR 2,400m and comparable EBIT of EUR 240m currently support only a 10.0% margin, whereas the target bridge requires EUR 575m of 2028E EBITDA at 8.0x, or EUR 4.60 bn before discounting. The base case assumes approximately 5.3 million saleable tonnes at EUR 566 per tonne, producing about EUR 3.0 bn of sales and EUR 575m of EBITDA after EUR 325m of fixed costs. Paso's optimised cash-cost target of approximately USD 280 per delivered tonne supports resilience, but Finnish wood costs, curtailments and Arauco Sucuriú and Paracel supply additions keep the cycle exposed.

Forest assets and wood sourcing — 19.0% · EUR 3,011m

Revenue EUR 400m (4.1%) · Comparable EBIT EUR 20m (2.2%, 5.0% margin) · EV EUR 3,011m

Forest assets and wood sourcing contributes only modelled revenue of EUR 400m and comparable EBIT of EUR 20m, yet receives 19.0% of allocated enterprise value because the operating allocation excludes much of the estate's real-asset and internal fibre value. UPM owns 917,000 hectares, reports more than EUR 3.5 bn of forest assets and harvested 7.8 million cubic metres from owned and leased forests in 2025. The target bridge uses EUR 300m of normalised economic EBITDA at 11.0x, producing EUR 3.30 bn, a 5.7% discount to the disclosed minimum asset value. Biological assets, taxes, conservation restrictions and harvesting obligations justify some discount, while Stora Enso's planned demerger of 1.2 million Swedish hectares could provide price discovery.

Energy — 12.0% · EUR 1,902m

Revenue EUR 480m (5.0%) · Comparable EBIT EUR 151m (16.4%, 24.6% margin on total sales) · EV EUR 1,902m

Energy produces EUR 480m of external revenue and EUR 151m of comparable EBIT, with a 24.6% margin on EUR 615m of total segment sales. Its 12.0% EV allocation reflects hydro and nuclear assets, UPM's position as Finland's second-largest electricity producer and a 54.3% stake in Pohjolan Voima. The target bridge requires EUR 210m of 2028E EBITDA at 10.0x, or EUR 2.10 bn. Finnish electricity demand is expected to grow 4–7% annually through 2030, but UPM's value depends on realised capture price and available generation rather than headline demand. Wind additions, negative-price periods, hydrology and nuclear outages can prevent the normalisation from EUR 151m of comparable EBIT to EUR 210m of EBITDA.

Adhesive Materials — 11.0% · EUR 1,743m

Revenue EUR 1,655m (17.1%) · Comparable EBIT EUR 124m (13.5%, 7.5% margin) · EV EUR 1,743m

Adhesive Materials earns EUR 1,655m of revenue and EUR 124m of comparable EBIT, but its 7.5% margin remains below the quality implied by a 2028E target of EUR 211.1m EBITDA at 9.0x. The valuation therefore depends on margin repair rather than aggressive revenue growth: the bridge assumes EUR 1.80 bn of revenue and an 11.7% EBITDA margin, driven by specialty mix, pricing and cost discipline. UPM is estimated to hold 4–7.3% of the relevant market, against Avery Dennison's 8–13.9%, although definitions differ. Avery's 9.5x 2026E EBITDA multiple is a ceiling rather than a direct benchmark because Avery has higher-value identification exposure and a 13.6% expected EBIT margin.

Biochemicals — 9.0% · EUR 1,426m

Revenue EUR 50m (0.5%) · Comparable EBIT -EUR 25m (-2.7%) · EV EUR 1,426m

Biochemicals is currently loss-making, with modelled revenue of EUR 50m and comparable EBIT of -EUR 25m, yet its 9.0% EV allocation reflects Leuna's potential rather than established earnings. The plant has 220,000 tonnes of annual nameplate capacity and requires EUR 990m of 2029 revenue at EUR 4,500 per tonne, a 30% gross margin and EUR 175m of EBITDA. Applying 8.0x EBITDA gives EUR 1.40 bn, close to the approximately EUR 1.3 bn project cost after the original EUR 550m estimate and a EUR 373m impairment. Stable separation and first industrial-sugar deliveries reduce technical risk, but repeat BioPura and functional-filler orders, integrated uptime and customer qualification remain unproven.

Specialty Papers — 7.0% · EUR 1,109m

Revenue EUR 1,108m (11.5%) · Comparable EBIT EUR 147m (16.0%, 11.2% margin) · EV EUR 1,109m

Specialty Papers generates EUR 1,108m of revenue and EUR 147m of comparable EBIT, an 11.2% margin that makes it one of the group's more profitable reported businesses. Its 7.0% EV allocation is below its 11.5% revenue and 16.0% EBIT shares because the target bridge applies 8.0x to EUR 143.75m of 2028E EBIT. Release-liner and packaging applications provide mix support, with release-liner substrate accounting for 55.6% of the cited glassine and kraft market. Asian stability in Q1 2026 is constructive, but capacity pressure and input costs limit the case for multiple expansion. The pool supports group cash generation without carrying the same project risk as Leuna.

Communication Papers — 6.0% · EUR 951m

Revenue EUR 2,459m (25.5%) · Comparable EBIT EUR 181m (19.7%, 7.3% margin) · EV EUR 951m

Communication Papers carries the group's largest revenue share at 25.5%, with modelled revenue of EUR 2,459m and comparable EBIT of EUR 181m, but receives only 6.0% of EV because European graphic-paper demand declined 8.0% in 2025. UPM has already closed 570,000 tonnes per year of capacity, and the target bridge applies 6.0x to EUR 141.667m of 2028E EBIT. The proposed Sappi joint venture could generate EUR 100m of annual synergies and EUR 613m of cash proceeds, but neither is separately capitalised in the target because regulatory remedies remain uncertain. The pool is therefore a managed-decline cash engine whose value depends on capacity leaving at least as quickly as demand.

Timber — 4.0% · EUR 634m

Revenue EUR 508m (5.3%) · Comparable EBIT EUR 43m (4.7%, 8.5% margin) · EV EUR 634m

Timber contributes modelled revenue of EUR 508m and comparable EBIT of EUR 43m, an 8.5% margin, while its 4.0% EV allocation reflects commodity exposure to lumber, sawlogs and energy. The 2028E bridge values EUR 81.25m of EBITDA at 8.0x, producing EUR 650m before discounting to the 12-month horizon and EUR 1.1 per share after discounting. Binderholz provides a 4.5 million cubic metre annual European scale reference, but UPM does not need to match that scale to support the allocation. The decisive spread is lumber less sawlog and energy costs. Persistent Finnish wood-cost inflation would weaken Timber economics and also undermine the broader value assigned to integrated sourcing.

Plywood — 3.0% · EUR 475m

Revenue EUR 389m (4.0%) · Comparable EBIT EUR 35m (3.8%, 8.6% margin) · EV EUR 475m

Plywood generates EUR 389m of revenue and EUR 35m of comparable EBIT, an 8.6% margin, and receives 3.0% of current EV. The bridge applies 8.0x to EUR 62.5m of 2028E EBIT, recognising the WISA brand and birch specialisation while retaining a cyclical wood-products discount. WISA has theoretical capacity of 785,000 cubic metres per year and an estimated 8–12% global share, although the market and share definitions are broad. The demerger effective date of 31 October 2026 creates an observable trading benchmark for a pool currently valued at EUR 475m. Completion can clarify standalone economics, but it does not remove exposure to wood costs, construction demand or plywood pricing.

Biofuels — 3.0% · EUR 475m

Revenue EUR 200m (2.1%) · Comparable EBIT EUR 15m (1.6%, 7.5% margin) · EV EUR 475m

Biofuels contributes modelled revenue of EUR 200m and comparable EBIT of EUR 15m, while its 3.0% EV allocation reflects regulated spread economics rather than scale alone. The target bridge applies 10.0x to EUR 110m of 2028E EBITDA. Lappeenranta has capacity of 130,000 tonnes or 120m litres, representing approximately 3.3% of EU HVO volume, and the product offers an 80% greenhouse-gas reduction versus fossil diesel. Finland's distribution obligation is 19.5% in 2026, including a four-percentage-point advanced-fuel sub-target. The valuation depends on RED III eligibility, crude tall-oil feedstock and renewable-fuel premiums; policy changes, excess HVO supply or Union Database problems could erode the spread.

Biomedical materials — 1.0% · EUR 158m

Revenue EUR 9m (0.1%) · Comparable EBIT -EUR 1m (-0.1%) · EV EUR 158m

Biomedical materials is an emerging option with modelled revenue of EUR 9m and comparable EBIT of -EUR 1m. The 1.0% EV allocation is not supported by current earnings; the 2029E bridge instead applies 2.0x to EUR 125m of revenue, producing a restrained strategic-option value. UPM's wood-derived animal-free hydrogels address niche applications, while Corning has a cited 48.91% scaffold share and CELLINK a 16.0% bio-ink share. The allocation assumes repeat commercial adoption rather than a proven earnings stream. Until customer uptake and product economics become visible, the pool remains too small to affect group earnings materially.

Reverse valuation

The reverse valuation tests the operating outcomes embedded in the share price and separates near-term delivery from long-term margin assumptions. The primary swing factor is normalised group EBITDA, with pulp spreads, Finnish wood costs, Energy capture and Leuna utilisation determining whether UPM earns the cash flow required by each case. The bridge also incorporates leverage and the multiple applied to that earnings base, so a weak operating outcome can reduce equity value through both lower enterprise value and persistent net debt.

Core investment analysis

How the company creates economic value

UPM creates value through a portfolio whose inputs and cash flows are not economically interchangeable. Pulp and plantations combine 5.8 million tonnes of capacity with the low-cost Paso de los Toros platform, where the optimised delivered cash-cost target is approximately USD 280 per tonne. Forest assets and wood sourcing add 917,000 owned hectares, more than EUR 3.5 bn of disclosed forest assets and 7.8 million cubic metres of owned-and-leased harvest. Energy adds hydro and nuclear exposure through a 54.3% PVO stake and produced EUR 151m of comparable EBIT on EUR 615m of total segment sales in 2025. Adhesive Materials and Specialty Papers contribute spread and mix economics, with EUR 124m and EUR 147m of comparable EBIT respectively in 2025. Communication Papers generated EUR 2,459m of modelled revenue but operates in an 8.0% declining European market, making closures and cash conversion more important than growth. Biofuels depends on regulatory premiums, while Leuna requires 220,000 tonnes of qualified product demand. The portfolio's strength is diversification across commodity, real-asset and emerging-material earnings; its weakness is that Finnish fibre costs and Leuna losses can absorb gains elsewhere. A separate valuation is therefore more informative than a single paper multiple and supports HOLD rather than a permanent conglomerate discount.

Putting the divisions back together

The bridge values each pool on a normalised earnings base and a multiple matched to its economics, then deducts EUR 2.741 bn of net debt and EUR 418m of other adjustments. Pulp contributes EUR 575m of 2028E EBITDA at 8.0x, Forest assets and wood sourcing EUR 300m at 11.0x, Energy EUR 210m at 10.0x and Adhesive Materials EUR 211.111m at 9.0x. Specialty Papers and Communication Papers are valued on EUR 143.75m and EUR 141.667m of EBIT at 8.0x and 6.0x, while Biochemicals requires EUR 175m of 2029E EBITDA at 8.0x. The resulting target enterprise value is EUR 17.80 bn. The reverse test shows what current price already requires: 2026E EBITDA of EUR 1.695 bn and a 9.5% EBIT margin, versus maintained-model EBITDA of EUR 1.846 bn and an 11.1% EBIT margin. At 8.58x 2026E EBITDA, current valuation is below the 9.5x peer median, but the discount reflects weaker returns and mix than historical averages. The quoted EV therefore rests partly on future execution: the gap between EUR 1.695 bn market-implied EBITDA and EUR 1.846 bn maintained EBITDA is EUR 151m, while forests and Energy provide separately auditable asset support. The target's central risk is not the multiple alone; it is whether normalised earnings materialise before leverage and restructuring absorb the benefit.

Scenarios and verdict

The bear case requires weak pulp spreads, high Finnish wood costs, poor Leuna utilisation, lower Energy capture and a failed or remedy-heavy Sappi transaction; it produces 12.93 EUR per share and -46.3%. The base case requires Paso de los Toros to deliver its cost position, modest Adhesive Materials margin repair, disciplined paper capacity and a credible path to Leuna's 2029 economics; it produces 27.77 EUR per share and +15.4%. The bull case requires stronger pulp pricing without major supply acceleration, high Energy capture, successful portfolio transactions and high-value biochemical qualification; it produces 37.82 EUR per share and +57.2%. Early indicators are realised pulp price and Finnish wood cost, Paso output, curtailment days, Energy capture price, repeat Leuna orders, start-up-cost progression and the European Commission's Sappi decision. The central debate is whether UPM's low-cost Uruguay pulp, forests and Energy can stabilise group cash flow before Finnish fibre costs, graphic-paper decline and Leuna execution overwhelm the portfolio. The observed evidence is mixed: H1 2026 comparable EBIT rose 17% to EUR 471m, but Kaukas requires a six-week shutdown, H2 maintenance effects are expected to be EUR 40m higher than H1 and Leuna's commercial output remains unproven. That balance supports HOLD until the earnings recovery becomes recurring.

Risks & catalysts

Downside risks

• Pulp-price decline and new hardwood supply (Forest assets and wood sourcing): lower realised pulp prices compress the delivered-cost spread as Arauco and Paracel capacity enters, with Chinese port inventories rising, BHKP prices falling and extended Finnish or Uruguay curtailments as the early warning - HIGH impact and a thesis-breaker if it occurs.
• Persistent Finnish wood-cost inflation (Timber): sawlog and pulpwood costs rise faster than lumber and pulp prices, with Fibres North remaining negative after maintenance normalises and purchased-wood volumes becoming more expensive as the early warning - HIGH impact and structural.
• Leuna fails to reach stable commercial output (Biochemicals): low yields, bottlenecks or weak qualification prevent 220,000 tonnes from producing EUR 990m of revenue and EUR 175m of EBITDA, with functional-filler deliveries slipping and start-up losses failing to peak during 2027 as the early warning - HIGH impact and a thesis-breaker if it occurs.
• UPM-Sappi transaction blocked or diluted (Communication Papers): a prohibition or onerous remedies remove EUR 613m of expected proceeds and weaken the EUR 100m annual synergy path, with major capacity disposals required or the 11 November decision delayed as the early warning - HIGH impact and manageable.
• Negative power prices reduce capture (Energy): wind additions and weak demand create more low-price hours and reduce nuclear realisation, with Finnish area prices discounting Nordic benchmarks and Energy margin falling below 20.0% of total segment sales as the early warning - MEDIUM impact and structural.

Upside catalysts

• WISA Group demerger becomes effective (near-term, Plywood): completion and first trading valuation provide independent price discovery for the EUR 475m pool.
• Commission decision on the UPM-Sappi joint venture (near-term, Communication Papers): clearance or proportionate remedies could unlock EUR 613m of proceeds and the EUR 100m annual synergy path.
• First repeat functional-filler deliveries (near-term, Biochemicals): customer orders after the initial September shipments would support the EUR 4,500 per tonne blended revenue assumption.
• Leuna reaches positive EBIT (medium-term, Biochemicals): positive divisional EBIT during 2027 would validate the EUR 1.40 bn target value.
• EUDR compliance becomes operational (medium-term, Forest assets and wood sourcing): traceable purchased wood by 30 December 2026 would protect sourcing access and the asset premium.

Financial statements & estimates

All figures in EUR millions unless noted; per-share data in EUR.

Income Statement

Balance Sheet

Cash Flow

Key Ratios & Multiples

UPM-Kymmene (UPM.HE) stock — frequently asked questions

Sources & methodology

• Primary data: Valuatum Equity Research, UPM-Kymmene Oyj report dated 1 September 2026 (the value-map allocations, anchor market capitalisation of EUR 12.7 bn and share price of 24.06 EUR). Forecasts and divisional allocations are analyst-maintained estimates rather than company guidance unless explicitly identified otherwise.
• Competitor context: Suzano at 4.6x 2026E EV/EBITDA, Holmen at 10.3x, Fortum at 13.0x, Avery Dennison at 9.5x and Borregaard at 9.3x. The cited competitor figures are not perfectly comparable: market definitions differ, Avery includes higher-value identification solutions, and Suzano reflects concentration, leverage and Brazilian risk.
• Market data: UPM.HE, 24.06 EUR as of 1 September 2026; the target bridge uses 2028E group and divisional EBITDA or EBIT, including EUR 575m of pulp EBITDA at 8.0x, EUR 300m of forest EBITDA at 11.0x, EUR 210m of Energy EBITDA at 10.0x and EUR 175m of Biochemicals EBITDA at 8.0x. Price sources and forecast figures should be independently verified before use.

Valuatum reports are generated using Valuatum's AI equity research framework — a structured enterprise-value and segment value methodology built on 25+ years of professional equity research practice. See the methodology for the full approach.

Related AI equity reports